News
News Center
2021-11-22
Develop specialized service platforms for gene therapy, cell therapy, immunotherapy, and other cutting-edge treatments that align with international standards, accelerating the translation and adoption of innovative therapeutic technologies.
+
2021-11-19
Recently, Yang Junyong, the actor who portrayed Jia Rong in the 1987 TV adaptation of "Dream of the Red Chamber," passed away unexpectedly at the age of 57 due to a sudden heart attack. His untimely departure has left many feeling deeply saddened—and serves as a stark reminder that autumn and winter are peak seasons for cardiovascular diseases, making it especially crucial to remain vigilant against the risk of acute myocardial infarction.
+
2021-11-15
The draft regulations (for public consultation) standardize the collection and storage of cells, provide specific guidelines for expanded clinical trial systems involving cell and gene therapies, and encourage the development and application of gene technology research.
+
2021-11-09
Messi recently underwent stem cell therapy in Madrid.
During the previous match between Paris Saint-Germain and Lille, Messi was substituted by teammate Icardi in the second half due to an injury. After the game, PSG officially announced that Messi is experiencing discomfort in his left hamstring and pain in his knee. As a result, Messi has chosen to undergo stem-cell therapy in Madrid, focusing on rehabilitating damaged tendons, muscles, and other affected tissues to facilitate full recovery.
+
2021-10-20
Jiuzhitang has been honored as a "Pioneer of Independent Innovation in China's Pharmaceutical Industry (50) – Private Enterprises," a "Top 100 Chinese Pharmaceutical Manufacturing Companies," and one of the "Top 50 Chinese Chain Drugstore Enterprises." Meanwhile, Li Zhenguo, Chairman of Jiuzhitang Co., Ltd. and President of Jiuzhitang Group, has earned the prestigious title of "One of China's Top 10 Leaders in the Pharmaceutical Industry."
+
2021-10-12
This year, we’ve once again made the list, earning the "2021 China Biopharmaceutical Company with the Greatest Growth Potential Award"—a testament to and recognition of our company’s remarkable breakthroughs and strong capabilities in the stem-cell field, as acknowledged by industry media and experts.
+
2021-10-09
On September 29, 2021, the official website of the Shanghai Municipal People's Government officially released the "Shanghai Plan for Building a Globally Influential Science and Technology Innovation Center during the 14th Five-Year Period."
+
2021-09-09
Stem cells are turning ALS from a "terminal illness" into something more manageable!
Stem cell therapy is already being applied in the treatment of various challenging and hard-to-treat diseases, and has demonstrated groundbreaking achievements in areas such as diabetes, chronic kidney disease, premature ovarian failure, and psoriasis. Looking ahead, it holds great promise to make significant strides in treating even more rare diseases, bringing hope to an increasing number of patients.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy